News and Events
Our Latest News
FOR IMMEDIATE RELEASE: Monday, August 28, 2023 Reprise Biomedical’s Miro3D® Wound Matrix Granted Level II HCPCS Code by CMS Minneapolis, MN, August 28, 2023 – Reprise Biomedical, Inc., a leading innovator in medical biotechnology for wound care, is pleased to announce...
Miro3D wound matrix featured as a Top 10 Innovations in Podiatry, from Podiatry Today, click to read more from Raymond Abdo, DPM. Risk Info: https://reprisebio.com/miro3d-risk/
Unique three-dimensional biologic matrix is now available to treat deep and tunneling wounds Minneapolis, Minn. (October 6, 2022) – Reprise Biomedical, Inc., an innovative medical device company focused on developing and commercializing biologic solutions using its...
Reprise Biomedical is pleased to announce that we have become a Corporate Member of the Wound, Ostomy, and Continence Nurses Society (WOCN). The WOCN Society is a professional community dedicated to advancing the practice and delivery of expert healthcare to...
Thanks to those who attended our webinar on Tuesday, January 19th 2021: Reducing Failure Rates in Hiatal and Paraesophageal Hernia Repair – the ‘Achilles Heel’ of Anti-reflux Surgery with Dr. G. Kevin Gillian. A full replay is available here. More information on...
The Florida Chapter, American College of Surgeons, and Reprise Biomedical are pleased to host a FREE Webinar
The Florida Chapter, American College of Surgeons, and Reprise Biomedical are pleased to host a FREE Webinar on Tuesday, January 19th, 2021 at 7:00 p.m. EST. Join us for a 45 min presentation followed by a Q&A session on “Reducing Failure Rates in Hiatal and...
Recent Research from Reprise Biomedical will be Highlighted at the Fall 2020 SAWC Virtual Meeting Poster Presentation: Treatment of Hard-To-Heal Diabetic Foot Ulcers With A Hepatic-Derived Wound Matrix (HD-WM) By: Dr. Robert Fridman, DPM, FACFAS, CWSP, Columbia...
Newly Published June 2020 in Wounds Journal: Treatment of Hard-to-heal Diabetic Foot Ulcers with a Novel Hepatic-Derived Wound Matrix. https://lnkd.in/eeMYNdn Read full article here: https://lnkd.in/efiXUkz For more info on MIRODERM: https://lnkd.in/esVgp-M
Reprise Biomedical supported MN healthcare workers by donating some of our extra personal protective equipment today. Our donation, with thoughtful inventory planning of what we could share, contributes to protecting our healthcare workers on the front lines today as...
New Minnesota-based medical device company focuses on biological medical devices manufactured using perfusion decellularization technology Minneapolis, Minn. (July 1, 2019) – Reprise Biomedical, Inc., a Minnesota-based startup focused on commercializing biological...
Reprise will be exhibiting at the following upcoming medical meetings:
|Mar 17-18||NPIAP 2023 Annual Conference||Booth 205||San Diego, CA|
|Apr 26-30||Symposium on Advanced Wound Care (SAWC) Spring||Booth 838||National Harbor, MD|
|Jun 4-7||WOCNext||Booth 300||Las Vegas, NV|
|Sep 21-23||APWCA Wound Week 2023
||Booth 23||Philadelphia, PA|
|Sep 21-23||42nd Annual Reconstructive surgery of the Foot, Ankle and Leg
||Booth TBD||San Diego, CA|
|Sep 28-30||DFCon ALPS 2023 Diabetic Foot Conference
||Booth 25||Anaheim, CA|
|Oct 6-7||ASPS 2023 Annual Conference
||Booth TBD||New Orleans, LA|
|Nov 2-5||Symposium on Advanced Wound Care (SAWC) Fall||Booth 340||Las Vegas, NV|